176 - 200 of 8587 Results
Title
Year
-
RESTRICTEDTitle: Synaptic tau: A pathological or physiological phenomenon?Journal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s40478-021-01246-yBest OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-021-01246-yCitation Count: 39
- How to proceed after “negative” exome: A review on genetic diagnostics, limitations, challenges, and emerging new multiomics techniques2022RESTRICTEDTitle: How to proceed after “negative” exome: A review on genetic diagnostics, limitations, challenges, and emerging new multiomics techniquesJournal Name: Journal of Inherited Metabolic DiseasePublisher: WileyVol: 45Issue #: 4Start Page: 663End Page: 681Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/jimd.12507Best OA location URL: https://repository.ubn.ru.nl/bitstream/handle/2066/282561/1/282561.pdfCitation Count: 20
-
RESTRICTEDTitle: GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 5Start Page: 1859End Page: 1872Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awac413Best OA location URL: https://academic.oup.com/brain/article-pdf/146/5/1859/50127735/awac413.pdfCitation Count: 11
- Risk of Chronic Cardiomyopathy Among Patients With the Acute Phase or Indeterminate Form of Chagas Disease2020RESTRICTEDTitle: Risk of Chronic Cardiomyopathy Among Patients With the Acute Phase or Indeterminate Form of Chagas DiseaseJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 3Issue #: 8Start Page: e2015072End Page: e2015072Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2020.15072Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2770045/chadalawada_2020_oi_200567_1602703565.56257.pdfCitation Count: 50
-
RESTRICTEDTitle: LRRK2 Phosphorylation, More Than an EpiphenomenonJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00527Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00527/pdfCitation Count: 41
-
RESTRICTEDTitle: Clinical implications of gastric complications on levodopa treatment in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 76Issue #:Start Page: 63End Page: 71Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.001Best OA location URL: http://www.prd-journal.com/article/S1353802020301103/pdfCitation Count: 42
-
RESTRICTEDTitle: Excitotoxicity Revisited: Mitochondria on the Verge of a Nervous BreakdownJournal Name: Trends in NeurosciencesPublisher: Elsevier BVVol: 44Issue #: 5Start Page: 342End Page: 351Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.tins.2021.01.001Best OA location URL: https://discovery.ucl.ac.uk/10122786/9/Duchen_071220_Plotegher%20et%20al._final.pdfCitation Count: 28
-
RESTRICTEDTitle: The Evolution-Driven Signature of Parkinson’s DiseaseJournal Name: Trends in NeurosciencesPublisher: Elsevier BVVol: 43Issue #: 7Start Page: 475End Page: 492Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.tins.2020.05.001Best OA location URL: https://doi.org/10.1016/j.tins.2020.05.001Citation Count: 23
-
RESTRICTEDTitle: Multidisciplinary Care to Optimize Functional Mobility in Parkinson DiseaseJournal Name: Clinics in Geriatric MedicinePublisher: Elsevier BVVol: 36Issue #: 1Start Page: 159End Page: 172Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cger.2019.09.008Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/214080/214080.pdfCitation Count: 19
- BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancer2020RESTRICTEDTitle: BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancerJournal Name: Lung CancerPublisher: Elsevier BVVol: 146Issue #:Start Page: 78End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.lungcan.2020.05.018Citation Count: 25
- Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global review2021RESTRICTEDTitle: Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global reviewJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 11Start Page: 3947End Page: 3960Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-021-10588-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-021-10588-5.pdfCitation Count: 28
- Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New Treatments2021RESTRICTEDTitle: Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New TreatmentsJournal Name: Archives of Medical ResearchPublisher: Elsevier BVVol: 52Issue #: 3Start Page: 243End Page: 251Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.arcmed.2020.10.021Citation Count: 25
- Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and Development2020RESTRICTEDTitle: Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and DevelopmentJournal Name: Therapeutic Innovation & Regulatory SciencePublisher: Springer Science and Business Media LLCVol: 54Issue #: 1Start Page: 103End Page: 116Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s43441-019-00034-0Citation Count: 27
- Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era2020RESTRICTEDTitle: Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine eraJournal Name: Medicinal Research ReviewsPublisher: WileyVol: 40Issue #: 6Start Page: 2650End Page: 2681Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/med.21718Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/med.21718Citation Count: 33
-
RESTRICTEDTitle: Upstream deregulation of calcium signaling in Parkinson’s diseaseJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2014.00053Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2014.00053/pdfCitation Count: 20
-
RESTRICTEDTitle: Parkinson’s disease-implicated kinases in the brain; insights into disease pathogenesisJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2014.00057Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2014.00057/pdfCitation Count: 67
-
RESTRICTEDTitle: Targeting Alpha-Synuclein as a Therapy for Parkinson’s DiseaseJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2019.00299Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2019.00299/pdfCitation Count: 217
-
RESTRICTEDTitle: New Developments in Genetic rat models of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 5Start Page: 717End Page: 729Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27296Best OA location URL: https://europepmc.org/articles/pmc5992003?pdf=renderCitation Count: 70
-
RESTRICTEDTitle: CNS-Derived Blood Exosomes as a Promising Source of Biomarkers: Opportunities and ChallengesJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2020.00038Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2020.00038/pdfCitation Count: 154
-
RESTRICTEDTitle: Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathiesJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 3Start Page: 372End Page: 390Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27344Best OA location URL: https://europepmc.org/articles/pmc5844369?pdf=renderCitation Count: 162
-
RESTRICTEDTitle: From reinforcement learning models to psychiatric and neurological disordersJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 14Issue #: 2Start Page: 154End Page: 162Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nn.2723Best OA location URL: https://europepmc.org/articles/pmc4408000?pdf=renderCitation Count: 648
-
RESTRICTEDTitle: Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?Journal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 7Start Page: 955End Page: 971Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27038Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27038Citation Count: 179
-
RESTRICTEDTitle: Which ante mortem clinical features predict progressive supranuclear palsy pathology?Journal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 7Start Page: 995End Page: 1005Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27034Best OA location URL: https://europepmc.org/articles/pmc5543934?pdf=renderCitation Count: 127
- The Neuroprotective Role of Protein Quality Control in Halting the Development of Alpha-Synuclein Pathology2017RESTRICTEDTitle: The Neuroprotective Role of Protein Quality Control in Halting the Development of Alpha-Synuclein PathologyJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2017.00311Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2017.00311/pdfCitation Count: 16
-
RESTRICTEDTitle: Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literatureJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 11Start Page: 1504End Page: 1523Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27193Best OA location URL: https://europepmc.org/articles/pmc5726430?pdf=renderCitation Count: 237